Organization Name:
Organization Website:
Social Issue:
Initiative/ Project Description:

In the 1980s, rising public health concerns about needle-stick injuries and their potential to transmit the HIV virus and other infections to healthcare workers led BD to develop new technology. In 1988, BD introduced the first safety syringe, incorporating a sliding safety shield to protect the needle after use, reducing the risk of injury and infection. The company paired this innovative technology with global partnerships to raise issue awareness, influence national policies on healthcare worker safety, and train health workers in safe injection practices.

Social Results:

At a global level, the incidence of health worker needle-stick injuries has been reduced by more than 50% due to technologies like BD's line of safety syringes. BD's work to forge partnerships with governments and advocacy groups led to policy changes in many countries, including the United States, the European Union, Russia, Brazil, and Taiwan.

Business Results:

BD's safety devices grew from approximately $5 million in revenue (1988) to approximately $250 million in revenue (1999) to $2.1 billion in revenue (2013). Sales of safety devices in emerging markets have accelerated, with 2012 growth of 25%, and over 42% growth in China alone, and have represented BD’s single largest source of growth over the past 25 years.  BD leaders anticipate that safety-engineered devices will continue to be a source of positive sales growth for the company over the next five to ten years, giving the company competitive advantage in a traditionally lower-margin, high-volume business.